My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Bill 16-19 Property Tax Abatement for Spectron mrc LLC
sbend
>
Public
>
Common Council
>
Legislation
>
Upcoming Bills
>
2016
>
03-14-16
>
Bill 16-19 Property Tax Abatement for Spectron mrc LLC
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/26/2017 10:13:00 AM
Creation date
3/10/2016 11:14:09 AM
Metadata
Fields
Template:
City Council - City Clerk
City Counci - Date
3/14/2016
Bill Number
Bill 16-19
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
18
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
Show annotations
View images
View plain text
Spectron mrc, LLC; Spectron Equipment, LLC; Spectron Land, LLC <br />Delaware LLCs <br />www.spectronmrc.com <br />ac carx� i tads ratalyst Two; Ignition Park, <br />Gregory S. Hiatt <br />17490 Dugdale Drive <br />Spectron mrc, LLC <br />Gregory S. Hiatt <br />leased <br />President(CEO /Man <br />574 - 271 -2800 <br />Indiana 46635, g.hiatt@spectronmrc.comorTAR( <br />Gregory S. Hiatt Prssident/CEO/Managing Director <br />same <br />none iMs r� f► M. FNA <br />Spectron mrc, LLC is a PET (positron emission tomography) radiopharmacy and radlophannaceutical manufacturer. The <br />company operates a cyclotron that creates positron emitting radioactive Isotopes for the use In manufacturing <br />pharmaceuticals used in nuclear medicine departments within hospitals and clinics. Additionally, Spectron mrc, fills <br />prescriptions written by focal physicians and distributes the prescriptions to the hospitals and clinics involved. <br />In addition to the hospitals and clinics using PET radiopharmaceu0cals, they also need and use, on a daily basis, a different <br />radionuclide for nuclear cardiology, nuclear bone imaging, lung, liver and kidney diagnostic studies. The radionuclide <br />needed is Technetium -99m and has had periods of product interruption over the last several years with the product <br />shortage situation predicted to get more severe in the years going forward. <br />The new business is to operate a higher energy cyclotron and produce the technetium -99m. The business plan is to <br />distribute compounded radiopharmaceuticals using the technetium -99m produced in our cyclotron. The hospitals and <br />clinics being serviced by our radiopharmacy (which Is a 2 to 3 hour delivery radius) wont be subject to the world wide <br />shortages. This business advantage these health care providers will have will improve 1 cap neetpc� <br />reputation of the focal health care facilities given that these healthcare providers will no have a¢) �pp��S t <br />other non - associated health care providers will have. The hospitals are very supportive f this I, <br />already signed long term supply /purchase agreements with Spectron mrc. <br />In the years ahead. Spectron mrc will be able to produce and supply other research, diagnostic aril theraoeutic <br />LYES I'IAK u Y 1016 <br />Is co ns 10 n o equipment has not been purchased nor installed <br />IN <br />
The URL can be used to link to this page
Your browser does not support the video tag.